肺腺癌 3.0 的术前和微创外科策略：从手术干预最佳时机中得到的经验教训。
Surgical Strategies for Pre- and Minimally Invasive Lung Adenocarcinoma 3.0: Lessons Learned From the Optimal Timing of Surgical Intervention.
机构信息
Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institute of Thoracic Oncology, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
出版信息
Semin Thorac Cardiovasc Surg. 2022 Spring;34(1):311-314. doi: 10.1053/j.semtcvs.2020.12.009. Epub 2021 Jan 12.
We discuss the optimal timing of surgery for lung cancer, and propose 3 surgical strategies for pre- and minimally invasive lung adenocarcinoma to avoid "overdiagnosis" and "overtreatment." Benign disease should not be treated as malignancy, pre- and minimally invasive disease should not be treated as invasive disease, and indolent malignancy should not be treated as aggressive malignancy.
我们讨论了肺癌手术的最佳时机，并提出了 3 种针对术前和微创肺腺癌的手术策略，以避免“过度诊断”和“过度治疗”。良性疾病不应被视为恶性肿瘤，术前和微创疾病不应被视为侵袭性疾病，惰性恶性肿瘤不应被视为侵袭性恶性肿瘤。
Zotero 插件